Nurix Therapeutics (NRIX) Amortizatization of Intangibles (2020 - 2026)

Nurix Therapeutics (NRIX) has 7 years of Amortizatization of Intangibles data on file, last reported at $2.0 million in Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $2.0 million, down 44.39% year-over-year; the trailing twelve-month figure through Feb 2026 was $8.5 million (down 2.29% YoY), and the FY2025 annual result was $10.1 million, up 42.28% from the prior year.
• Amortizatization of Intangibles advanced to $2.0 million in Q1 2026 per NRIX's latest filing, from $1.7 million in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $3.8 million in Q3 2025 and troughed at -$3.7 million in Q3 2022.
• A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Amortizatization of Intangibles.
• On a YoY basis, Amortizatization of Intangibles climbed as much as 668.47% in 2022 and fell as far as 222.73% in 2022.
• A 5-year view of Amortizatization of Intangibles shows it stood at $650000.0 in 2022, then soared by 72.77% to $1.1 million in 2023, then soared by 56.19% to $1.8 million in 2024, then dropped by 5.3% to $1.7 million in 2025, then climbed by 19.08% to $2.0 million in 2026.
• Business Quant data shows NRIX's Amortizatization of Intangibles at $2.0 million in Q1 2026, $1.7 million in Q4 2025, and $3.8 million in Q3 2025.